239 Physician experiences and perceptions of systemic therapies for atopic dermatitis in the United States

This cross-sectional, survey-based study assessed US physicians experiences and perceptions of the risks and benefits of non-biologic systemic therapies, prior to the introduction of biologics, for moderate-to-severe atopic dermatitis (AD). Physicians specializing in dermatology, allergy/immunology or primary care, who prescribed oral systemic immunosuppressants (IMMs) or steroids (SSs) for AD, and who had ≥10 office visits for AD in the year prior to selection were identified from the HealthCore Integrated Research Database (08/01/1511/04/16).

Source: Journal of Investigative Dermatology - April 19, 2018 Category: Dermatology Authors: A.W. Armstrong, M. Grabner, J. Stephenson, R. Zhao, U.G. Mallya, N. Bieszk, R. Miao, A. Gadkari, J. Chao Tags: Clinical Research: Epidemiology of Skin Diseases Source Type: research